Evoke Pharma, Inc. (EVOK) Insider Trading Activity

NASDAQ$2.87-0.02 (-0.69%)
Market Cap
$4.32M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
565 of 872
Rank in Industry
38 of 52

EVOK Insider Trading Activity

EVOK Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$180
1
100

Related Transactions

Nantahala Capital Management, LLC10 percent owner
0
$0
1
$180
$-180

About Evoke Pharma, Inc.

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Insider Activity of Evoke Pharma, Inc.

Over the last 12 months, insiders at Evoke Pharma, Inc. have bought $0 and sold $180 worth of Evoke Pharma, Inc. stock.

On average, over the past 5 years, insiders at Evoke Pharma, Inc. have bought $0 and sold $172,012 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 500,000 shares for transaction amount of $1.18M was made by LVP GP III, LLC (10 percent owner) on 2018‑08‑20.

List of Insider Buy and Sell Transactions, Evoke Pharma, Inc.

2025-01-28SaleNantahala Capital Management, LLC10 percent owner
41
0.0027%
$4.39
$180
-26.52%
2020-12-14SaleGonyer David APresident and CEO
23,954
0.0936%
$2.94
$70,425
-54.58%
2020-12-11SaleGonyer David APresident and CEO
48,046
0.1885%
$2.90
$139,333
-53.45%
2020-12-11SaleD'Onofrio Matthew JExec VP, Chief Bus. Officer
40,357
0.1589%
$2.91
$117,439
-53.45%
2020-12-10SaleD'Onofrio Matthew JExec VP, Chief Bus. Officer
5,643
0.0226%
$2.95
$16,647
-53.29%
2018-08-20PurchaseLVP GP III, LLC10 percent owner
500,000
2.8821%
$2.35
$1.18M
-2.52%
2017-02-22PurchaseWIDDER KENNETH Jdirector
450,000
3.0145%
$2.90
$1.3M
-17.03%
2016-05-26SaleDOMAIN PARTERS VII L P10 percent owner
688,240
8.3615%
$4.70
$3.23M
-52.42%
2016-05-26SaleDP VII ASSOCIATES LP10 percent owner
11,760
0.1429%
$4.70
$55,272
-52.42%
2016-04-27SaleDOMAIN PARTERS VII L P10 percent owner
7,206
0.1042%
$5.02
$36,174
-46.99%
2016-04-27SaleDP VII ASSOCIATES LP10 percent owner
122
0.0018%
$5.02
$612
-46.99%
2016-04-25SaleDOMAIN PARTERS VII L P10 percent owner
2,984
0.0409%
$5.20
$15,517
-51.43%
2016-04-25SaleDP VII ASSOCIATES LP10 percent owner
42
0.0006%
$5.20
$218
-51.43%
2016-04-20SaleDOMAIN PARTERS VII L P10 percent owner
8,848
0.1254%
$5.29
$46,806
-50.19%
2016-04-20SaleDP VII ASSOCIATES LP10 percent owner
152
0.0022%
$5.29
$804
-50.19%
2016-04-19SaleDOMAIN PARTERS VII L P10 percent owner
74,108
1.0666%
$5.36
$397,219
-50.00%
2016-04-19SaleDP VII ASSOCIATES LP10 percent owner
1,264
0.0182%
$5.36
$6,775
-50.00%
2016-04-11SaleDOMAIN PARTERS VII L P10 percent owner
8,696
0.1207%
$5.22
$45,393
-50.10%
2016-04-11SaleDP VII ASSOCIATES LP10 percent owner
150
0.0021%
$5.22
$783
-50.10%
2016-04-08SaleDOMAIN PARTERS VII L P10 percent owner
29,108
0.4165%
$5.35
$155,728
-50.19%
Total: 34
*Gray background shows transactions not older than one year

EVOK Institutional Investors: Active Positions

Increased Positions3+33.33%25,049+11.47%
Decreased Positions2-22.22%1,299-0.59%
New Positions2New25,016New
Sold Out Positions<1Sold Out1,258Sold Out
Total Postitions10+11.11%242,206+10.87%

EVOK Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Nantahala Capital Management, Llc$458.0014.82%148,194+91,945+163.46%2024-12-31
Bleichroeder Lp$212.006.88%68,75000%2024-12-31
Ubs Group Ag$4.000.13%1,258+1,168+1,297.78%2024-12-31
Blackrock, Inc.$00.01%12200%2025-03-31
Sbi Securities Co., Ltd.$00.01%7500%2025-03-31
Morgan Stanley$0<0.01%3100%2024-12-31
Newedge Advisors, Llc$0<0.01%1700%2024-12-31
Bank Of America Corp /De/$0<0.01%9-16-64%2024-12-31
Citigroup Inc$00%0-4Sold Out2024-12-31
Aigh Capital Management Llc$00%0-70,546Sold Out2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.